Cordis sp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2011-06-16
Share capital
40,000.00 PLN
Registered address
Klemensa Janickiego 4, 88-400 Żnin, Poland
Industry
Authorized Representatives
Jarosław Zajdler – President of the Management Board
Manner of representation
In the case of a one-person management board – the member of the management board independently. In the case of a multi-member management board – two members of the management board jointly or a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Izabela Maria Sołkiewicz | 200 | $5,402.49 | 50% |
Jarosław Zajdler | 200 | $5,402.49 | 50% |
Beneficial owners
No beneficial owners recorded for the company Cordis.
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 12, 2019 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Neuca S.A. | $3,426,322,199.90 | inwestor.neuca.pl | ||
| Idalia Ludwikowscy sp. j. | $41,868,843.38 | idalia.com.pl | ||
| Centrum Zaopatrzenia Medycznego Cezal - Wrocław S.A. | $25,656,815.87 | cezal.com.pl | ||
| Dutchmed Pl sp. z o.o. | $6,460,098.71 | dutchmed.pl | ||
| Przedsiębiorstwo Handlowe Lines sp. z o.o. | $5,548,056.66 | lines.com.pl | ||
| Strażak sp. z o.o. | $3,098,112.37 | strazak.torun.pl | ||
| Panacea-Diagnostyka sp. z o.o. | $270,780.69 | panacea.net.pl | ||
| Mimic Poland sp. z o.o. | $85,589.70 | mimic.com.pl | ||
| EDGE Pharma sp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Biodermatic sp. j. | – | biodermatic.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-06-23 | Liquidation opened | |
| 2011-06-16 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on June 16, 2011.
The headquarters is located at: Klemensa Janickiego 4, 88-400 Żnin.
The share capital of the company is PLN 40,000 (approx. $10,805).
The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.
Last updated: 2026-10-21